Market Cap ₹93 Cr.
Stock P/E 0.0
P/B 2.5
Current Price ₹131.3
Book Value ₹ 52.4
Face Value 10
52W High ₹163
Dividend Yield 0%
52W Low ₹ 103.2
Ambani Organics Ltd manufactures, processes, imports, and substances water based speciality chemicals in India. The company's merchandise comprises organic peroxides, along with tertiary butyl hydro peroxide, di-benzoyl peroxide, and methyl ethyl ketone peroxide; paint driers; accelerators; acrylic emulsions; di-tertiary butyl peroxide, tertiary butyl peroxy, and silver-ion disinfectants. Its products are used in numerous business programs, together with paper, adhesive, carpet, construction, timber, paint, composite/FRP, textile, and pharmaceutical. The company additionally exports its merchandise. Ambani Organics Ltd was founded in 1985 and is based in Mumbai, India.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Mar 2021 | Mar 2022 |
---|---|---|
Net Sales | 0 | 0 |
Other Income | 0 | 0 |
Total Income | 0 | 0 |
Total Expenditure | 0 | 0 |
Operating Profit | 0 | 0 |
Interest | 0 | 0 |
Depreciation | 0 | 0 |
Exceptional Income / Expenses | 0 | 0 |
Profit Before Tax | 0 | 0 |
Provision for Tax | 0 | 0 |
Profit After Tax | 0 | 0 |
Adjustments | 0 | 0 |
Profit After Adjustments | 0 | 0 |
Adjusted Earnings Per Share | 0 | 0 |
#(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|
Net Sales | 52 | 65 | 80 | 73 | 87 | 125 | 132 | 0 |
Other Income | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 0 |
Total Income | 53 | 66 | 80 | 73 | 87 | 126 | 133 | 0 |
Total Expenditure | 49 | 61 | 74 | 68 | 81 | 119 | 124 | 0 |
Operating Profit | 4 | 5 | 6 | 6 | 7 | 7 | 9 | 0 |
Interest | 2 | 2 | 3 | 3 | 3 | 3 | 4 | 0 |
Depreciation | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 |
Exceptional Income / Expenses | -0 | 0 | -0 | -0 | 0 | 0 | -0 | 0 |
Profit Before Tax | 1 | 2 | 2 | 2 | 3 | 3 | 3 | 0 |
Provision for Tax | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 |
Profit After Tax | 1 | 2 | 2 | 1 | 2 | 2 | 2 | 0 |
Adjustments | 0 | 0 | 0 | -0 | -0 | -0 | -0 | 0 |
Profit After Adjustments | 1 | 2 | 2 | 1 | 2 | 2 | 2 | 0 |
Adjusted Earnings Per Share | 0 | 4.6 | 3.4 | 2.7 | 3.3 | 2.7 | 2 | 0 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 6% | 22% | 15% | 0% |
Operating Profit CAGR | 29% | 14% | 12% | 0% |
PAT CAGR | 0% | 26% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | -12% | 8% | 13% | NA% |
ROE Average | 6% | 8% | 10% | 15% |
ROCE Average | 8% | 10% | 13% | 15% |
#(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|
Shareholder's Funds | 4 | 6 | 15 | 17 | 19 | 36 | 38 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 2 | 3 | 2 | 2 | 6 | 12 | 24 |
Other Non-Current Liabilities | 5 | 6 | 7 | 9 | 9 | 9 | 9 |
Total Current Liabilities | 26 | 33 | 38 | 35 | 45 | 55 | 67 |
Total Liabilities | 38 | 47 | 61 | 62 | 78 | 112 | 137 |
Fixed Assets | 12 | 13 | 13 | 15 | 21 | 22 | 21 |
Other Non-Current Assets | 0 | 0 | 0 | 2 | 0 | 18 | 49 |
Total Current Assets | 26 | 34 | 48 | 46 | 56 | 72 | 67 |
Total Assets | 38 | 47 | 61 | 62 | 78 | 112 | 137 |
#(Fig in Cr.) | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 1 | 1 | 1 | 3 | 3 | 3 | 11 |
Cash Flow from Operating Activities | 4 | 3 | -2 | 5 | -4 | -0 | 17 |
Cash Flow from Investing Activities | -2 | -2 | -1 | -3 | -6 | -20 | -38 |
Cash Flow from Financing Activities | -2 | -1 | 5 | -2 | 10 | 27 | 16 |
Net Cash Inflow / Outflow | -0 | 0 | 3 | -1 | 1 | 7 | -5 |
Closing Cash & Cash Equivalent | 1 | 1 | 3 | 3 | 3 | 11 | 6 |
# | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | 2.1 | 4.64 | 3.4 | 2.72 | 3.35 | 2.67 | 2.01 |
CEPS(Rs) | 3.35 | 6.31 | 4.73 | 4.34 | 5.38 | 5.32 | 5.34 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Book NAV/Share(Rs) | 10.84 | 15.45 | 30.41 | 33.14 | 36.49 | 47.69 | 49.7 |
Core EBITDA Margin(%) | 6.17 | 6.12 | 5.97 | 6.27 | 6.01 | 4.49 | 5.28 |
EBIT Margin(%) | 5.93 | 5.67 | 5.34 | 5.74 | 5.73 | 4.24 | 4.78 |
Pre Tax Margin(%) | 2.25 | 2.79 | 2.58 | 2.7 | 2.66 | 1.96 | 1.99 |
PAT Margin (%) | 1.53 | 2.33 | 1.86 | 1.63 | 1.73 | 1.41 | 1.31 |
Cash Profit Margin (%) | 2.44 | 3.18 | 2.58 | 2.6 | 2.78 | 2.39 | 2.27 |
ROA(%) | 2.12 | 4.15 | 3.17 | 2.23 | 2.43 | 2.12 | 1.59 |
ROE(%) | 19.37 | 35.28 | 16.19 | 8.57 | 9.63 | 8.17 | 6.31 |
ROCE(%) | 18.59 | 22.21 | 19.05 | 14.54 | 12.62 | 8.92 | 7.69 |
Receivable days | 112.21 | 83.1 | 80.33 | 98.88 | 99.34 | 79.23 | 72.61 |
Inventory Days | 43.84 | 40.18 | 53.93 | 72.52 | 63.85 | 49.92 | 53.51 |
Payable days | 129.43 | 117.74 | 120.58 | 124.3 | 82.79 | 59.07 | 66.35 |
PER(x) | 0 | 0 | 19.44 | 22.45 | 13.73 | 41.13 | 40.27 |
Price/Book(x) | 0 | 0 | 2.17 | 1.85 | 1.26 | 2.31 | 1.63 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EV/Net Sales(x) | 0.3 | 0.29 | 0.56 | 0.66 | 0.62 | 0.9 | 0.9 |
EV/Core EBITDA(x) | 4.15 | 3.88 | 7.49 | 8.31 | 8.2 | 15.12 | 13.6 |
Net Sales Growth(%) | 0 | 24.71 | 22.08 | -8.58 | 18.93 | 44.22 | 5.64 |
EBIT Growth(%) | 0 | 38.2 | 15.74 | -2 | 15.58 | 7.74 | 19.11 |
PAT Growth(%) | 0 | 120.99 | -2.28 | -19.89 | 23.01 | 18.17 | -1.69 |
EPS Growth(%) | 0 | 120.99 | -26.68 | -19.89 | 23 | -20.16 | -24.8 |
Debt/Equity(x) | 3.05 | 2.73 | 0.96 | 1.18 | 1.83 | 1.3 | 1.77 |
Current Ratio(x) | 0.98 | 1.04 | 1.27 | 1.31 | 1.26 | 1.3 | 1.01 |
Quick Ratio(x) | 0.74 | 0.72 | 0.81 | 0.84 | 0.86 | 0.91 | 0.67 |
Interest Cover(x) | 1.61 | 1.97 | 1.94 | 1.89 | 1.87 | 1.86 | 1.72 |
Total Debt/Mcap(x) | 0 | 0 | 0.44 | 0.64 | 1.45 | 0.67 | 1.28 |
# | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 72.67 | 72.67 | 72.67 | 72.67 | 72.67 | 63.59 | 63.59 | 63.59 | 63.59 | 57.95 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 27.33 | 27.33 | 27.33 | 27.33 | 27.33 | 36.41 | 36.41 | 36.41 | 36.41 | 42.05 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Sep 2019 | Mar 2020 | Sep 2020 | Mar 2021 | Sep 2021 | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.37 | 0.37 | 0.37 | 0.37 | 0.37 | 0.41 | 0.41 | 0.41 | 0.41 | 0.41 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 0.14 | 0.14 | 0.14 | 0.14 | 0.14 | 0.23 | 0.23 | 0.23 | 0.23 | 0.3 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 0.51 | 0.51 | 0.51 | 0.51 | 0.51 | 0.64 | 0.64 | 0.64 | 0.64 | 0.71 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About